211 related articles for article (PubMed ID: 17094333)
1. Leflunomide in clinical practice.
Pinto P; Dougados M
Acta Reumatol Port; 2006; 31(3):215-24. PubMed ID: 17094333
[TBL] [Abstract][Full Text] [Related]
2. Safety evaluation of leflunomide in rheumatoid arthritis.
Keen HI; Conaghan PG; Tett SE
Expert Opin Drug Saf; 2013 Jul; 12(4):581-8. PubMed ID: 23668332
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action for leflunomide in rheumatoid arthritis.
Fox RI; Herrmann ML; Frangou CG; Wahl GM; Morris RE; Strand V; Kirschbaum BJ
Clin Immunol; 1999 Dec; 93(3):198-208. PubMed ID: 10600330
[TBL] [Abstract][Full Text] [Related]
4. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
Karanikolas G; Charalambopoulos D; Andrianakos A; Antoniades C; Katsilambros N
J Rheumatol; 2006 Mar; 33(3):486-9. PubMed ID: 16511917
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of leflunomide in rheumatoid arthritis.
Fox RI
J Rheumatol Suppl; 1998 Jul; 53():20-6. PubMed ID: 9666414
[TBL] [Abstract][Full Text] [Related]
6. Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
Perdriger A; Mariette X; Kuntz JL; Brocq O; Kara-Terki R; Loet XL; Cantagrel A; Pavy S; Deslandre CJ; Debiais F; Combe B;
J Rheumatol; 2006 May; 33(5):865-9. PubMed ID: 16652418
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide Aventis Pharma.
Kaplan MJ
Curr Opin Investig Drugs; 2001 Feb; 2(2):222-30. PubMed ID: 11816835
[TBL] [Abstract][Full Text] [Related]
8. The effect of exon (19C>A) dihydroorotate dehydrogenase gene polymorphism on rheumatoid arthritis treatment with leflunomide.
Pawlik A; Herczynska M; Kurzawski M; Safranow K; Dziedziejko V; Drozdzik M
Pharmacogenomics; 2009 Feb; 10(2):303-9. PubMed ID: 19207032
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide.
Cannon GW; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
[TBL] [Abstract][Full Text] [Related]
10. The broadening use of leflunomide in clinical practice.
Kiely PD
Hosp Med; 2004 Dec; 65(12):735-9. PubMed ID: 15624449
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of rheumatoid and psoriatic arthritis--review of leflunomide].
Babić-Naglić D; Anić B; Novak S; Grazio S; Martinavić Kaliterna D
Reumatizam; 2010; 57(2):161-2. PubMed ID: 21875023
[No Abstract] [Full Text] [Related]
13. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
Herrmann ML; Schleyerbach R; Kirschbaum BJ
Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide-associated pancytopenia with or without methotrexate.
Chan J; Sanders DC; Du L; Pillans PI
Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
Rajakulendran S; Gadsby K; Deighton C
Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
[TBL] [Abstract][Full Text] [Related]
16. Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis.
O'Doherty C; Schnabl M; Spargo L; Cleland LG; James M; Proudman SM; Wiese MD
Pharmacogenomics; 2012 Sep; 13(12):1427-34. PubMed ID: 22966891
[TBL] [Abstract][Full Text] [Related]
17. Is leflunomide as safe and effective in the treatment of rheumatoid arthritis as other DMARDs?
Schooff M; Wickersham J
Am Fam Physician; 2003 Sep; 68(5):849-50. PubMed ID: 13678131
[No Abstract] [Full Text] [Related]
18. Antimetabolites in the treatment of arthritis: current status of the use of antimetabolites.
Dijkmans BA; Jansen G
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1083-8. PubMed ID: 15571207
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Breedveld FC; Dayer JM
Ann Rheum Dis; 2000 Nov; 59(11):841-9. PubMed ID: 11053058
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients.
Siva C; Eisen SA; Shepherd R; Cunningham F; Fang MA; Finch W; Salisbury D; Singh JA; Stern R; Zarabadi SA
Arthritis Rheum; 2003 Dec; 49(6):745-51. PubMed ID: 14673959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
